Global spread of autoimmune disease blamed on western diet

Latest articles

Abbisko Therapeutics and Lilly partner to develop new molecules
Abbisko Therapeutics and Lilly partner to develop new molecules

Abbisko is eligible to receive up to $258m in milestone payments from Lilly.

Read
Moderna eyes combined Covid-19, flu booster by 2023
Moderna eyes combined Covid-19, flu booster by 2023

Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.

Read
AstraZeneca-Daiichi Sankyo’s breast cancer therapy gets FDA priority review
AstraZeneca-Daiichi Sankyo’s breast cancer therapy gets FDA priority review

The sBLA is based on results from the international, open-label Phase III DESTINY-Breast03 trial of Enhertu.

Read
Covid-19 update: Fourth shot of vaccine can’t prevent Omicron infections
Covid-19 update: Fourth shot of vaccine can’t prevent Omicron infections

Global: The global Covid death toll has passed the grim milestone of 5.5 million, with a figure of 5,545,923 according…

Read
Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19
Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19

The authorised dosage is two tablets of nirmatrelvir and one tablet of ritonavir given orally twice daily for five days.

Read
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19

The company will collaborate with the University of NSW and Macquarie University for vaccine development.

Read
GSK rejects Unilever’s $68.4bn offer for Consumer Healthcare business
GSK rejects Unilever’s $68.4bn offer for Consumer Healthcare business

GSK noted that the bids ‘fundamentally undervalued’ the Consumer Healthcare business.

Read
Covid-19 news: Billionth Covax program vaccine delivered
Covid-19 news: Billionth Covax program vaccine delivered

Global: The global Covid-19 death toll has passed the grim milestone of 5.5 million, with a figure of 5,539,681 according…

Read

Who we are

Our company

Our know-how.

Our desire to write.

About us
Team in office

Topics

Our range of topics is wide, so we always have something to write. We want to share our know-how.

Architecture

Art & Music

Beauty

Architecture

All articles
No items found.

Art & Music

All articles
No items found.

Beauty

All articles
No items found.

Do you like our stuff? Subscribe now.

Five main reasons to sign up for our newsletter